Medindia
Medindia LOGIN REGISTER
Advertisement

Biodel Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference April 30th 2008

Wednesday, April 23, 2008 General News
Advertisement
DANBURY, Conn., April 22 Biodel Inc.(Nasdaq: BIOD) today announced that Dr. Solomon Steiner, CEO and Chairman ofBiodel, will present a corporate update at the Morgan Stanley GlobalHealthcare Unplugged Conference on Wednesday, April 30, 2008 at 10:30 a.m.Eastern Time. The conference will be held at the Ritz-Carlton Key Biscayne inKey Biscayne, Florida.
Advertisement

Interested parties may access a link to a live webcast of the corporatepresentation in the investor relations section of Biodel's website atwww.biodel.com. An archive of the presentation will be available at the samelocation.
Advertisement

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on thedevelopment and commercialization of innovative treatments for endocrinedisorders, such as diabetes and osteoporosis. Biodel's product candidates aredeveloped by using VIAdel(TM) technology, which reformulates existingFDA-approved peptide drugs. The Company's lead product candidate,VIAject(TM), is an ultra rapid-acting injectable meal-time insulin indevelopment for use by patients with Type 1 or Type 2 diabetes. VIAject(TM)is currently being tested in two pivotal Phase III clinical trials. Biodel'spipeline also includes VIAtab(TM), a sublingual tablet formulation of insulinin the Phase I stage of clinical testing, and two pre-clinical osteoporosisproduct candidates. For further information regarding Biodel, please visitthe Company's website at www.biodel.com.

BIOD-G

SOURCE Biodel Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close